Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Chief Business Officer acquired 1,368 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 2,018 shares (grant or award)
  5. 4 Grant or award Chief Scientific Officer acquired 846 shares (grant or award)
  6. 4 Open-market buy Director bought 1,000 shares at $5.78 ($5,785)
  7. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $5.20 ($51,996)
  8. 4 Gift Chief Medical Officer gave 67,787 shares (gift)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes President and CEO gave up 27,214 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Medical Officer gave up 7,990 shares (to pay taxes)
  16. 4 Grant or award Chief Business Officer acquired 2,614 shares (grant or award)
  17. 4 Shares withheld for taxes Chief Scientific Officer gave up 6,826 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Scientific Officer gave up 4,264 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Business Officer gave up 3,862 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Medical Officer gave up 4,994 shares (to pay taxes)

Page 4 of 34 · 674 filings